Related references
Note: Only part of the references are listed.Evaluation of pharmacokinetics of single-dose primaquine in undernourished versus normally nourished children diagnosed with Plasmodium vivax malaria in Mumbai
N. J. Gogtay et al.
JOURNAL OF POSTGRADUATE MEDICINE (2021)
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group
Kelly E. Caudle et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Prevalence of CYP2D6 Genotypes and Predicted Phenotypes in a Cohort of Cambodians at High Risk for Infections with Plasmodium vivax
Michele D. Spring et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Doses of primaquine administered to children withPlasmodium vivaxaccording to an age-based dose regimen
Michelle Valeria Dias Ferreira Vieira et al.
PATHOGENS AND GLOBAL HEALTH (2020)
Chloroquine Versus Dihydroartemisinin- Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria
Cindy S. Chu et al.
CLINICAL INFECTIOUS DISEASES (2019)
High sensitivity methods to quantify chloroquine and its metabolite in human blood samples using LC-MS/MS
Karnrawee Kaewkhao et al.
BIOANALYSIS (2019)
8-Aminoquinoline Therapy for Latent Malaria
J. Kevin Baird
CLINICAL MICROBIOLOGY REVIEWS (2019)
Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
Walter R. J. Taylor et al.
LANCET (2019)
Antimalarial activity of primaquine operates via a two-step biochemical relay
Grazia Camarda et al.
NATURE COMMUNICATIONS (2019)
Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry
Bharathi Avula et al.
MALARIA JOURNAL (2018)
Real time PCR detection of common CYP2D6 genetic variants and its application in a Karen population study
Kanokpich Puaprasert et al.
MALARIA JOURNAL (2018)
Association of Impaired Cytochrome P450 2D6 Activity Genotype and Phenotype With Therapeutic Efficacy of Primaquine Treatment for Latent Plasmodium vivax Malaria
J. Kevin Baird et al.
JAMA NETWORK OPEN (2018)
Age, Weight, and CYP2D6 Genotype Are Major Determinants of Primaquine Pharmacokinetics in African Children
Bronner P. Goncalves et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Pharmacokinetic Properties of Single-Dose Primaquine in Papua New Guinean Children: Feasibility of Abbreviated High-Dose Regimens for Radical Cure of Vivax Malaria
Brioni R. Moore et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Open-Label Crossover Study of Primaquine and Dihydroartemisinin-Piperaquine Pharmacokinetics in Healthy Adult Thai Subjects
Borimas Hanboonkunupakarn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Pharmacokinetic Interactions between Primaquine and Chloroquine
Sasithon Pukrittayakamee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis
Ric N. Price et al.
LANCET INFECTIOUS DISEASES (2014)
The metabolism of primaquine to its active metabolite is dependent on CYP 2D6
Brandon S. Pybus et al.
MALARIA JOURNAL (2013)
Primaquine Failure and Cytochrome P-450 2D6 in Plasmodium vivax Malaria
Jason W. Bennett et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Cytochrome P450 variations in different ethnic populations
Joseph McGraw et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
GENETIC POLYMORPHISM IN CYTOCHROME P450 2D6 (CYP2D6): POPULATION DISTRIBUTION OF CYP2D6 ACTIVITY
Patricia Neafsey et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS (2009)
The CYP2D6 activity score: Translating genotype information into a qualitative measure of phenotype
A. Gaedigk et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Methemoglobin - It's not just blue: A concise review
Jay Umbreit
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use
P Dorado et al.
BIOTECHNIQUES (2005)
Share Paper
